According to Biolase
's latest financial reports the company has $6.93 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | $4.18 M | -86.05% |
2021-12-31 | $29.97 M | 70.64% |
2020-12-31 | $17.56 M | 203.4% |
2019-12-31 | $5.78 M | -28.03% |
2018-12-31 | $8.04 M | -30.92% |
2017-12-31 | $11.64 M | 30.49% |
2016-12-31 | $8.92 M | -23.72% |
2015-12-31 | $11.69 M | -62.93% |
2014-12-31 | $31.56 M | 2091.67% |
2013-12-31 | $1.44 M | -43.37% |
2012-12-31 | $2.54 M | -23.1% |
2011-12-31 | $3.3 M | 95.22% |
2010-12-31 | $1.69 M | -43.06% |
2009-12-31 | $2.97 M | -73.52% |
2008-12-31 | $11.23 M | -22.87% |
2007-12-31 | $14.56 M | -0.75% |
2006-12-31 | $14.67 M | -19.07% |
2005-12-31 | $18.13 M | -42.37% |
2004-12-31 | $31.46 M | 183.2% |
2003-12-31 | $11.11 M | 182.01% |
2002-12-31 | $3.94 M | 47.57% |
2001-12-31 | $2.67 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
![]() Align Technology
ALGN | $1.00 B | 14,441.99% | ๐บ๐ธ USA |
![]() Dentsply Sirona
XRAY | $0.29 B | 4,156.85% | ๐บ๐ธ USA |